Step by Stepa HemeOncBuddy patient portal

Ivosidenib

Illustration: Ivosidenib

Say it: eye-voe-SID-e-nib · Brand names: Tibsovo

Ivosidenib is a targeted pill that blocks a faulty enzyme in some leukemias and bile duct cancers.

What it is

Some cancers have a change in a gene called IDH1 (isocitrate dehydrogenase 1). The faulty enzyme makes a substance that keeps blood cells from maturing normally. Ivosidenib blocks this enzyme, which helps blood cells grow up normally again and slows some cancers.

Often used for

How you get it

Ivosidenib is a tablet you take by mouth once a day. For acute myeloid leukemia it is sometimes given with another medicine called azacitidine. It may take a few months to see the full effect. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Ivosidenib?
Ivosidenib is a targeted pill that blocks a faulty enzyme in some leukemias and bile duct cancers. Brand names: Tibsovo.
What is Ivosidenib used for?
acute myeloid leukemia (AML) with an IDH1 gene change; myelodysplastic syndrome (a bone marrow disorder) with an IDH1 gene change that came back; bile duct cancer (cholangiocarcinoma) with an IDH1 gene change.
How is Ivosidenib given?
Ivosidenib is a tablet you take by mouth once a day. For acute myeloid leukemia it is sometimes given with another medicine called azacitidine. It may take a few months to see the full effect. Your schedule may be different.
What are the common side effects of Ivosidenib?
Feeling tired. Joint pain. Diarrhea or nausea. Swelling in the legs or feet. Mouth sores. Cough or shortness of breath. Less appetite or belly pain.
When should I call my care team while taking Ivosidenib?
Fever, trouble breathing, cough, chest pain, fast weight gain, swelling, dizziness, or urinating less, which can be signs of differentiation syndrome; A fast, pounding or uneven heartbeat, dizziness, fainting, or chest discomfort; Weakness, numbness or tingling in the legs or arms that spreads, or trouble breathing or swallowing; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.